Delivery Order SPE2DB20D3303-SPE2DB23FA1PH
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Gilenya 0.5 mg capsules to support medical supply needs. The $19,335.84 firm fixed-price contract was awarded on May 19, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award, valued at $48,546.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the supply of Gilenya 0.5 mg capsules. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $76,971.35 delivery order is for the pharmaceutical product Gilenya 0.5 mg capsules and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract is for the delivery of Gilenya 0.5 mg capsules, a specialty medication, with a ceiling value of $26,943.61 and a performance period through October 2023. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $23,656.42 Firm Fixed Price delivery order is for the pharmaceutical product Gilenya 0.5 mg capsules. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,282.08 firm fixed-price delivery order is for the supply of 30-count capsules of the drug Gilenya 0.5 mg. This contract has a completion date of May 2, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, which does not have a set-aside designation, is a Delivery Order valued at $88,020.56 for the provision of the medication Gilenya 0.5 mg capsules. The award has an ultimate completion date of December 2, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,761.96 delivery order is for the supply of Gilenya 0.5 mg capsules, a specialty pharmaceutical used for the treatment of multiple sclerosis. The award is not associated with a set-aside designation, indicating it was competed on an open basis. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Gilenya 0.5 mg capsules. The contract has a ceiling value of $26,277.64 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a part of the U.S. Department of Defense (DoD). The contract, valued at $8,002.76, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Gilenya 0.5 mg capsules, a prescription medication, to support DoD and other government healthcare...